DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Warfarin
Drug: Apixaban

First Posted Date: 2021-02-03

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 19002

Registration Number: NCT04736719

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

Completed

Conditions: Heart Failure

Interventions: Drug: ACE inhibitor
Drug: Sacubitril/Valsartan

First Posted Date: 2021-02-03

Last Posted Date: 2023-08-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 6066

Registration Number: NCT04736433

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Rivaroxaban
Drug: Warfarin

First Posted Date: 2021-02-03

Last Posted Date: 2023-07-28

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 78605

Registration Number: NCT04736420

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data

Completed

Conditions: Osteoporosis

Interventions: Drug: Zoledronic Acid
Drug: Raloxifene

First Posted Date: 2021-02-03

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 18028

Registration Number: NCT04736693

Locations: 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States

Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Dabigatran
Drug: Warfarin

First Posted Date: 2021-02-03

Last Posted Date: 2023-08-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 5350

Registration Number: NCT04735523

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

A Nurse-led, Advance Care Planning Intervention in the Emergency Department

Not Applicable

Completed

Conditions: Emergency Department
Advance Care Planning
Motivational Interviewing

Interventions: Behavioral: ED GOAL Nursing

First Posted Date: 2021-01-29

Last Posted Date: 2022-06-24

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 76

Registration Number: NCT04730986

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)

Phase 1

Conditions: Chronic Kidney Diseases
Hyperkalemia

Interventions: Drug: Sodium Zirconium Cyclosilicate Oral Product

First Posted Date: 2021-01-27

Last Posted Date: 2021-02-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 20

Registration Number: NCT04727840

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Microdevice in Ovarian, Fallopian Tube, and Peritoneal Cancer

Phase 1

Recruiting

Conditions: Peritoneal Cancer
Fallopian Tube Cancer Stage IV
Fallopian Tube Cancer
Ovarian Cancer Stage III
Fallopian Tube Cancer Stage III
Ovarian Cancer
Ovarian Cancer Stage IV

Interventions: Combination Product: Microdevice

First Posted Date: 2021-01-08

Last Posted Date: 2025-02-05

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 20

Registration Number: NCT04701645

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Methotrexate
Drug: Hydroxychloroquine

First Posted Date: 2020-12-31

Last Posted Date: 2021-11-23

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 133553

Registration Number: NCT04691505

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Validation of Circadian Biomarkers in Patients With Sleep Disorders

Completed

Conditions: Advanced Sleep Phase Syndrome (ASPS)
Sleep Disorders, Circadian Rhythm
Circadian Rhythm Sleep Disorder
Delayed Sleep Phase Syndrome
Circadian Rhythm Disorders
Sleep Wake Disorders
Sleep Disorder

First Posted Date: 2020-12-30

Last Posted Date: 2024-08-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 50

Registration Number: NCT04690504

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy